Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.

Raggam, R B; Wagner, J; Prüller, F; Grisold, A; Leitner, E; Zollner-Schwetz, I; Valentin, T; Krause, R; Hoenigl, M

Raggam, R B; Wagner, J; Prüller, F; Grisold, A; Leitner, E; Zollner-Schwetz, I; Valentin, T; Krause, R; Hoenigl, M.

Affiliation

Raggam RB; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

J Intern Med ; 276(6): 651-8, 2014 Dec.

Article in En | MEDLINE | ID: mdl-24645798

Subject(s)

Receptors, Urokinase Plasminogen Activator/blood; Systemic Inflammatory Response Syndrome/blood; Systemic Inflammatory Response Syndrome/mortality; Age Factors; Aged; Area Under Curve; Biomarkers/blood; C-Reactive Protein/analysis; Calcitonin/blood; Calcitonin Gene-Related Peptide; Creatinine/blood; Female; Glycoproteins/blood; Humans; Interleukin-6/blood; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Prospective Studies; Protein Precursors/blood; ROC Curve; Regression Analysis

Key words

laboratory biomarker; mortality, prediction; soluble urokinase plasminogen activator receptor; systemic inflammatory response syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / Receptors, Urokinase Plasminogen Activator Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Intern Med Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google